20/20 Onsite Information

2020 Onsite (also known as 20/20 Onsite) is a specialty vendor for sponsors and CROs conducting clinical trials with ocular endpoints, providing end-to-end ophthalmic trial consultation, clinical field execution, and ongoing support. Through a single-call accountability model, 20/20 Onsite helps sponsors de-risk ocular endpoint complexity and increase the likelihood of on-time, on-budget, protocol-adherent trial success. Its proprietary point-of-need service delivery model reaches participants where they live, work, or congregate, reducing patient burden, improving retention, and supporting diverse enrollment strategies. Backed by proven expertise, nationwide experience at scale, and validated regulatory rigor, 20/20 Onsite has supported more than 45 clinical trials, served over 100,000 patients, and consistently delivered Net Promoter Scores above 95. To learn more about how 2020 Onsite (20/20 Onsite) delivers single-call ophthalmic execution for trials with ocular endpoints, visit www.2020onsite.com.